Extracorporeal CO2 Removal Devices Size, Share, & Strategies|2030
[Research Report] The extracorporeal CO2 removal devices market is projected to grow from US$ 99.93 million in 2022 to US$ 170.54 million by 2030; the market is estimated to record a CAGR of 6.9% during 2022–2030.
Market Insights and Analyst View:
Factors such as the increasing cases of chronic obstructive pulmonary diseases (COPD) and growing geriatric population propel the extracorporeal CO2 removal devices market growth. However, strict mandates related to extracorporeal CO2 removal devices impede the growth of the market.
Extracorporeal CO2 removal devices are safe, effective, and feasible. The use of extracorporeal CO2 removal devices for ventilatory support has been suggested in clinical situations where they may be useful in addressing the exacerbations of COPD and acute respiratory distress syndrome. Several manufacturers focus on developing technologically advanced and innovative extracorporeal CO2 removal devices and strengthening their market position. Further, an increasing number of elderly people prone to COPD are being cannulated to extracorporeal CO2 removal devices to improve their survival rates. Therefore, the increasing incidences of pulmonary obstructive diseases are among the factors contributing to the growing extracorporeal CO2 removal devices marketsize. On the contrary, the use of extracorporeal CO2 removal devices carries the risk of infection, hypoxemia, or thrombosis arising from restricted blood flow through the circulatory system can lead to serious health problems and pose a long-term challenge to the market expansion.
Growth Drivers:
Increasing Cases of Chronic Obstructive Pulmonary Diseases Drives Extracorporeal CO2 Removal Devices Market
According to the Burden of Disease Study in 2019, 212.3 million cases of COPD and 3.3 million COPD-related deaths were documented globally. One of the major reasons for respiratory diseases such as COPD is the growing air pollution. Further, the Organization for Economic Co-operation and Development (OECD) states that the global emissions of greenhouse gases are expected to surge by ~50% by 2050, owing to an increase in CO2 emissions to 70%. In addition, it estimated that the atmospheric concentration of greenhouse gases could reach 685 parts per million (ppm) CO2 equivalent by 2050, which would cause average temperatures to rise 3–6°C above pre-industrial levels.
In January 2021, as per the study published in the journal PLoS ONE, about 2.6 million people in France suffered from COPD. By 2025, this number is expected to rise to 2.8 million. According to 2022 statistics published by National Health Science, approximately 1.17 million people were diagnosed with COPD in England in 2020–21, representing 1.9% of the total population. According to the WHO, COPD is considered the third leading cause of death worldwide, causing approximately 3.2 million deaths in 2022. Additionally, more than 11 million people in the US are diagnosed with COPD each year, according to the American Lung Association. Therefore, the high burden of COPD in the population increases the demand for extracorporeal CO2 removal devices for vitalization of blood flow and efficient gas exchange, thereby driving the extracorporeal CO2 removal devices market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Extracorporeal CO2 Removal Devices Market: Strategic Insights
Market Size Value in US$ 99.93 million in 2022 Market Size Value by US$ 170.54 million by 2030 Growth rate CAGR of 6.9% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Extracorporeal CO2 Removal Devices Market: Strategic Insights
![extracorporeal-co2-removal-market](https://www.theinsightpartners.com/assets/rdimages/extracorporeal-co2-removal-market-img1.png)
Market Size Value in | US$ 99.93 million in 2022 |
Market Size Value by | US$ 170.54 million by 2030 |
Growth rate | CAGR of 6.9% from 2022 to 2030 |
Forecast Period | 2022-2030 |
Base Year | 2022 |
![Analyst Image](https://www.theinsightpartners.com/assets/mrinal_kerhalkar.jpg)
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
![Analyst Image](https://www.theinsightpartners.com/assets/images/speak_analyst.gif)
Report Segmentation and Scope:
The “extracorporeal CO2 removal devices market analysis” has been carried out by considering the following segments: product, application, and end user.
Segmental Analysis:
By application, the extracorporeal CO2 removal devices market is segmented into acute respiratory distress syndrome, chronic obstructive pulmonary disease, and others. The chronic obstructive pulmonary disease segment held the largest market share in 2022. The acute respiratory distress syndrome segment is anticipated to register the highest CAGR of 7.7% during the forecast period. Increasing awareness of ARDS and its early detection has resulted in more patients being diagnosed and treated, resulting in a greater demand for extracorporeal CO2 removal devices tailored for ARDS management. As a result, healthcare providers have become more confident in incorporating extracorporeal CO2 removal devices into their ARDS treatment protocols.
Extracorporeal CO2 removal devices allow a reduction in respiratory rate and tidal volume, resulting in a prolonged expiratory time that is better adapted to the high expiratory time constant of the respiratory system. According to the British Lung Association, there are around 1.2 million people in the UK living with diagnosed COPD. The increasing prevalence of COPD is, therefore, predicted to accelerate the extracorporeal CO2 removal devices market worldwide.
The extracorporeal CO2 removal devices market, by product, is divided into extracorporeal CO2 devices and consumables. The extracorporeal CO2 devices segment held a larger market share in 2022. The consumables segment is anticipated to register a higher CAGR of 7.6% during the forecast period. Due to technical simplification, extracorporeal CO2 removal devices require a few personnel and logistics, thereby increasing patient preference. This led the extracorporeal CO2 removal devices segment to secure its market position.
The process of extracorporeal CO2 removal requires a fresh set of consumables for every patient, owing to which there is a high demand for consumables in various COPD and ARDS-related procedures. Thus, the extracorporeal CO2 removal devices market for the consumables segment is expected to continue to grow during the forecast period.
By end user, the market is categorized into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest extracorporeal CO2 removal devices market share in 2022 and is anticipated to register the highest CAGR of 7.4% during the forecast period. Hospitals, particularly those with specialized intensive care units (ICUs) and respiratory facilities, are equipped to care for the most seriously ill patients. In addition, hospitals typically have multidisciplinary teams of healthcare professionals, including pulmonologists, critical care physicians, respiratory therapists, and perfusionists, who work together to treat patients with complex respiratory needs. This expertise is essential for the safe and effective use of ECCO2R devices.
Growing Technological Advancements to Accelerate Extracorporeal CO2 Removal Devices Market
Smaller extracorporeal CO2 removal devices are less invasive and more comfortable for patients. They often require smaller vascular access, reducing the risk of complications. As patients are not tied to large, immobile devices, they can experience greater mobility and comfort, which results in improving the entire quality of treatment. Advances in membrane technology have significantly improved the effectiveness and efficacy of extracorporeal CO2 removal devices. They selectively allow the diffusion of CO2 while retaining important blood components such as red blood cells and proteins. This selectivity minimizes the risk of hemolysis and other blood-related complications.
As there is a greater need to maintain quality of life in the geriatric population due to their deteriorating health conditions, extracorporeal CO2 removal devices play an important role in providing less invasive and gentler respiratory support. Technological advances in extracorporeal CO2 removal (ECCO2R) have led to the development of more user-friendly and portable devices. As its benefits are increasingly recognized, ECCO2R is increasingly being incorporated into treatment plans for older adults. Thus, growing technological advancements will likely bring new extracorporeal CO2 removal devices market trends in the coming years.
Regional Analysis:
The scope of the extracorporeal CO2 removal devices market report entails North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
In 2022, North America held the largest extracorporeal CO2 removal devices market share. The market growth in this region is driven by improved healthcare infrastructure and high adoption of extracorporeal CO2 removal devices, especially during the COVID-19 pandemic in the US and Canada. Early adoption of new technologies and a large patient pool for ARDS and COPD are expected to accelerate the growth of the market in the region. The increasing incidence of chronic respiratory diseases and preference for safe and rapid minimally invasive ventilators are further expected to accelerate the growth of the extracorporeal CO2 removal devices market during the forecast period.
The extracorporeal CO2 removal devices market in Europe is expected to occupy the second-largest share of the global market. This is due to the increasing demand for healthcare devices coupled with the increasing prevalence of chronic diseases such as respiratory failure in the region. Further, favorable reimbursement policies, increasing government investments in long-term healthcare, and growing healthcare research infrastructures are increasing the utilization rates of extracorporeal CO2 removal devices.
The extracorporeal CO2 removal devices market in Asia Pacific is expected to witness the fastest growth rate of 7.3% during the forecast period. The growth is due to a large patient pool, growing awareness of acute respiratory failure, and increasing government healthcare spending in developing countries such as India and Japan. Further, multinational companies look forward to investing in developing countries like China and thereby boosting the market growth in the region.
Extracorporeal CO2 Removal Devices Market Report Scope
Industry Developments and Future Opportunities:
The extracorporeal CO2 removal devices market forecast can help stakeholders in this marketplace plan their growth strategies. A few strategic developments by leading players operating in the market are listed below:
- In October 2022, ALung Technologies evaluated the safety and effectiveness of using the hemolung respiratory assist system (RAS) for low-flow extracorporeal CO2 removal (ECCO2R) as an alternative or adjunct to invasive mechanical ventilation for patients requiring respiratory support due to acute exacerbations of chronic obstructive pulmonary disease (COPD).
- In March 2022, Respira Labs, a US-based respiratory health technology company, launched Sylvee. This AI-powered wearable lung monitor uses acoustic resonance to assess lung function and identify lung volume fluctuations. It can help detect and treat chronic obstructive pulmonary disease, asthma, and COVID-19.
- In May 2021, ALung Technologies, Inc. received FDA clearance for its next-generation Hemolung RAS extracorporeal CO2 removal system, designed to provide respiratory support to patients with acute respiratory failure.
- In May 2020, ALung Technologies, Inc. announced the commercial development of the next-generation artificial lung called the hemolung RAS.
Competitive Landscape and Key Companies:
Getinge, ALung Technologies, Inc.; Estor, NovaLung GmbH, Hemodec, Baxter Healthcare, Eurosets, LivaNova, Medtronic, and Xenios AG are among the prominent companies profiled in the extracorporeal CO2 removal devices market report. These companies focus on developing new technologies, upgrading existing products, and expanding their geographic presence to meet the growing consumer demand worldwide.
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
Product, Application, End User, and Geography
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors driving the growth of the extracorporeal CO2 removal devices market include the increasing cases of chronic obstructive pulmonary diseases (COPD) and growing geriatric population.
The extracorporeal CO2 removal devices market majorly consists of the players such as Getinge, ALung Technologies, Inc.; Estor, NovaLung GmbH, Hemodec, Baxter Healthcare, Eurosets, LivaNova, Medtronic, and Xenios AG.
Extracorporeal CO2 removal devices are an efficient therapy for patients with hypercapnic respiratory failure. They can enable doctors and healthcare professionals to improve lung protective ventilation. Extracorporeal CO2 removal devices can remove enough CO2 to reduce alveolar minute ventilation by 50%, significantly reducing the partial pressure of carbon dioxide (PaCO2). Therefore, various advantages of extracorporeal CO2 removal devices are expected to increase the overall market development.
The global extracorporeal CO2 removal devices market, based on product is bifurcated into extracorporeal CO2 devices and consumables. The extracorporeal CO2 devices segment held a larger market share in 2022. The consumables segment is anticipated to register a higher CAGR of 7.6% during the forecast period. Based on application, the market is segmented into acute respiratory distress syndrome, chronic obstructive pulmonary disease, and others. The chronic obstructive pulmonary disease segment held the largest market share in 2022. The acute respiratory distress syndrome segment is anticipated to register the highest CAGR of 7.7% during 2022–2030. In terms of end user, the extracorporeal CO2 removal devices market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest extracorporeal CO2 removal devices market share in 2022 and is anticipated to register the highest CAGR of 7.4% during 2022–2030.
The hyperbaric oxygen therapy market was valued at US$ 99.93 million in 2022.
The hyperbaric oxygen therapy market is expected to be valued at US$ 170.54 million in 2030.
1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Extracorporeal CO2 Removal Devices Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Extracorporeal CO2 Removal Devices Market - Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Extracorporeal CO2 Removal Devices Market - Global Market Analysis
6.1 Extracorporeal CO2 Removal Devices - Global Market Overview
6.2 Extracorporeal CO2 Removal Devices - Global Market and Forecast to 2030
7. Extracorporeal CO2 Removal Devices Market – Revenue Analysis (USD Million) – By Product, 2020-2030
7.1 Overview
7.2 Extracorporeal CO2 Devices
7.3 Consumables
8. Extracorporeal CO2 Removal Devices Market – Revenue Analysis (USD Million) – By Application, 2020-2030
8.1 Overview
8.2 Chronic Obstructive Pulmonary Disease
8.3 Acute Respiratory Distress Syndrome
8.4 Others
9. Extracorporeal CO2 Removal Devices Market – Revenue Analysis (USD Million) – By End User, 2020-2030
9.1 Overview
9.2 Hospitals and Clinics
9.3 Ambulatory Surgical Centers
9.4 Others
10. Extracorporeal CO2 Removal Devices Market - Revenue Analysis (USD Million), 2020-2030 – Geographical Analysis
10.1 North America
10.1.1 North America Extracorporeal CO2 Removal Devices Market Overview
10.1.2 North America Extracorporeal CO2 Removal Devices Market Revenue and Forecasts to 2030
10.1.3 North America Extracorporeal CO2 Removal Devices Market Revenue and Forecasts and Analysis - By Product
10.1.4 North America Extracorporeal CO2 Removal Devices Market Revenue and Forecasts and Analysis - By Application
10.1.5 North America Extracorporeal CO2 Removal Devices Market Revenue and Forecasts and Analysis - By End User
10.1.6 North America Extracorporeal CO2 Removal Devices Market Revenue and Forecasts and Analysis - By Countries
10.1.6.1 United States Extracorporeal CO2 Removal Devices Market
10.1.6.1.1 United States Extracorporeal CO2 Removal Devices Market, by Product
10.1.6.1.2 United States Extracorporeal CO2 Removal Devices Market, by Application
10.1.6.1.3 United States Extracorporeal CO2 Removal Devices Market, by End User
10.1.6.2 Canada Extracorporeal CO2 Removal Devices Market
10.1.6.2.1 Canada Extracorporeal CO2 Removal Devices Market, by Product
10.1.6.2.2 Canada Extracorporeal CO2 Removal Devices Market, by Application
10.1.6.2.3 Canada Extracorporeal CO2 Removal Devices Market, by End User
10.1.6.3 Mexico Extracorporeal CO2 Removal Devices Market
10.1.6.3.1 Mexico Extracorporeal CO2 Removal Devices Market, by Product
10.1.6.3.2 Mexico Extracorporeal CO2 Removal Devices Market, by Application
10.1.6.3.3 Mexico Extracorporeal CO2 Removal Devices Market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Rest of Europe
10.3 Asia-Pacific
10.3.1 Australia
10.3.2 China
10.3.3 India
10.3.4 Japan
10.3.5 South Korea
10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
10.4.1 South Africa
10.4.2 Saudi Arabia
10.4.3 U.A.E
10.4.4 Rest of Middle East and Africa
10.5 South and Central America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Rest of South and Central America
11. Industry Landscape
11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments
12. Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration
13. Extracorporeal CO2 Removal Devices Market - Key Company Profiles
13.1 Getinge AB
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
Note - Similar information would be provided for below list of companies
13.2 ALung Technologies, Inc.
13.3 Xenios AG
13.4 Estor SpA
13.5 Medtronic
13.6 Hemodec
13.7 NovaLung GmbH
13.8 Baxter Healthcare
13.9 Eurosets
13.10 LivaNova
14. Appendix
14.1 Glossary
14.2 About The Insight Partners
14.3 Market Intelligence Cloud
The List of Companies - Extracorporeal CO2 Removal Devices Market
- Getinge
- ALung Technologies, Inc.
- Estor
- NovaLung GmbH
- Hemodec
- Baxter Healthcare
- Eurosets
- LivaNova
- Medtronic
- Xenios AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.